Lab Confirmation Testing Kit Market Introduction
This Lab Confirmation Testing Kit market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study.
This study is one of the most comprehensive documentation that captures all the facets of the evolving Lab Confirmation Testing Kit market.
COVID-19, also known as coronavirus disease, is continuing to spread globally with confirmed cases now surpassing 9,60,000 cases. With skyrocketing confirmed incidences of COVID-19, pharma, healthcare workers, universities as well as institutes are working tirelessly day and night to discover or develop cure for the life-threatening virus.
Request a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11270
The Urgent Need for Diagnostic Kits
At this point of time, an effective and efficient diagnosis of this alarmingly spreading virus would immensely help in curbing its spread all around the world.
Developing a widely accessible, inexpensive point-of-care diagnostic kit requires an accountable leadership, decisive science-based governance, significant financing, and the application of reliable principle-based scientific protocols to determine whom to test, how to interpret results, and how best to treat and quarantine those infected.
Such measures would not only help contain the current COVD-19 epidemic; it can also create a system for developing similar tools to stop future pandemics. Thus, by taking the lead in creating such an infrastructure, the US can help itself and the rest of the world as well. According to Mediheroes, made-in-Korea diagnostic kits that have not won FDA’s emergency use authorization are likely to be used in USA.
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-11270
Key Segments of Lab Confirmation Testing Kit Market
On the basis of Modularity:
- Rack mount
- Portable
On the basis of end use:
- Automotive
- Chemical
- Agriculture
- Oil and Gas
- Research and Development
- Others
Bosch’s Rapid COVID-19 Rest is on the Way
The brain of Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company, Randox Laboratories Ltd. is Bosch’s rapid COVID-19 test. This brand-new, fully automated test is expected to aid medical facilities – doctors, laboratories, hospitals, healthcare centers – diagnose faster.
To quote Dr. VolkmarDenner, chairman of the board of management of Robert Bosch GmbH, “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up identification and isolation of infected patients”.
Bosch’s rapid COVID-19 test delivered result with an accuracy of over 95 percent when tested in various laboratories with SARS-CoV-2. The most unique feature of Bosch Vivalytic analyzer is that it can perform up to 10 tests in 24 hours; meaning only 100 devices can evaluate up to 1000 tests per day.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/11270
Bosch’s rapid test can detect a SARS-CoV-2 coronavirus infection in just two and a half hours (includes the time the sample is taken to the time the result arrives). The ability of the test being performed at the point of care itself is an added boon. It is in talks that these newly developed tests will be available in Germany in April, with emerging markets in Europe and elsewhere.
Mologic Developing Test Kits for COVID-19
Mologic had earlier created test kits for measles, Ebola and yellow fever. The lab confirmation test kits created by Mologic would be validated by specialists in the Liverpool School of Tropical Medicine, the Wuhan Institute of Virology, the London University, the University of Malaya, Malaysia and Fiocruz in Brazil. A successfully developed and validated, a much faster way to test and diagnose Covid-19 could prove critical at this hour of crisis.
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs